Aug 2026 (Q1 FY27) — Oct 8, 2026
Tilray Brands Q1 FY27 — Record revenue and gross margin expansion on BrewDog; adjusted EBITDA guide reaffirmed
Read the full callTilray Brands earnings: last reported Thu, 8 Oct 2026, for the quarter ended Aug 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 257 | +22.7% YoY | Quarterly, as filed | Quarter to Aug 2026 | Revenue from operations as filed. |
| Operating margin | -9.3 | −10.3 pts YoY | Operating profit / revenue | Quarter to Aug 2026 | For the quarter; a change is in percentage points. |
| Net profit | -43.1 | Quarterly, as filed | Quarter to Aug 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $15.6 on 17 Oct 2025 → $3.03. High $15.7 (20 Oct 2025), low $3.03 (19 Oct 2026).
Overview
Call summaries
Tilray Brands Q1 FY27 — Record revenue and gross margin expansion on BrewDog; adjusted EBITDA guide reaffirmed
Read the full callTilray Brands Q4 FY26 — Diversified Growth and Strengthened Financials
Read the full callEvery analysed call
Financials
Net profit, year on year: −13298% (quarter to aug 2026 against aug 2025).
| Line item | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 211 | 186 | 225 | 210 | 218 | 207 | 282 | 257 |
| Operating profit | -42 | -760 | -1,444 | 2 | -22 | -26 | -16 | -24 |
| Operating margin | −20.0% | −409.1% | −643.1% | 1.0% | −10.2% | −12.8% | −5.8% | −9.3% |
| Other income | -33 | -24 | 55 | 4 | -12 | 8 | -1 | -8 |
| Profit before tax | -83 | -792 | -1,393 | -1 | -40 | -23 | -24 | -38 |
| Tax rate | −2.5% | −0.1% | 9.0% | 296.0% | −8.9% | −8.5% | −57.6% | −4.5% |
| Net profit | -85 | -789 | -1,273 | -0 | -45 | -27 | -50 | -43 |
| EPS ($ per share) | -0.99 | -8.69 | — | 0 | -0.41 | -0.24 | — | -0.32 |
| Line item | May 2020 | Dec 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -113 | -730 | -486 | -963 | -2,416 | -2,660 | -4,847 | -4,969 |
| Total liabilities | 463 | 572 | 1,560 | 1,008 | 977 | 778 | 585 | 733 |
| Fixed assets | 421 | 200 | 651 | 587 | 430 | 558 | 568 | 680 |
| Investments | — | — | — | 0 | 242 | 32 | 35 | 5 |
| Total assets | 1,738 | 946 | 6,025 | 5,450 | 4,307 | 4,222 | 2,074 | 2,328 |
| Line item | May 2020 | Dec 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -101 | -129 | -45 | -177 | 8 | -31 | -95 | -69 |
| Cash from investing | -70 | -42 | 46 | -22 | -285 | 128 | -47 | -56 |
| Cash from financing | 131 | 265 | 124 | 128 | 70 | -75 | 134 | 131 |
| Net cash flow | -47 | 93 | 128 | -73 | -209 | 22 | -7 | 8 |
| Capital expenditure | -99 | -45 | -39 | -34 | -21 | -29 | -33 | — |
| Free cash flow | -199 | -174 | -84 | -211 | -13 | -60 | -128 | — |
46 filings between Jan 7, 2026 and Aug 26, 2026.
Purchases
$69.2K
3 purchases by 3 insiders
Sales
$232.9K
1 sale by 1 insider
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hopkinson David G. | — | $232.9K | Apr 21, 2026 |
| Merton Carl A | $46.2K | — | Aug 4, 2026 |
| FALTISCHEK DENISE M | $11.9K | — | Aug 3, 2026 |
| Gendel Mitchell | $11.1K | — | Aug 6, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | SIMON IRWIN D President and CEO | Tax withheld | 216,561 | $1.06M |
| Aug 26, 2026 | Gendel Mitchell Global General Counsel | Option exercise | 109,748 | $0 |
| Aug 26, 2026 | Gendel Mitchell Global General Counsel | Tax withheld | 26,795 | $130.8K |
| Aug 26, 2026 | Gendel Mitchell Global General Counsel | Option exercise | 50,556 | $0 |
| Aug 26, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Tax withheld | 63,610 | $310.4K |
| Aug 26, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | 120,017 | $0 |
| Aug 26, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Tax withheld | 30,849 | $150.5K |
| Aug 26, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | 58,204 | $0 |
| Aug 26, 2026 | SIMON IRWIN D President and CEO | Option exercise | 408,605 | $0 |
| Aug 26, 2026 | SIMON IRWIN D President and CEO | Tax withheld | 425,889 | $2.08M |
| Aug 26, 2026 | Merton Carl A Chief Financial Officer | Tax withheld | 31,559 | $154.0K |
| Aug 26, 2026 | Merton Carl A Chief Financial Officer | Option exercise | 57,380 | $0 |
| Aug 26, 2026 | Gendel Mitchell Global General Counsel | Tax withheld | 58,167 | $283.9K |
| Aug 26, 2026 | Merton Carl A Chief Financial Officer | Tax withheld | 61,090 | $298.1K |
| Aug 26, 2026 | Merton Carl A Chief Financial Officer | Option exercise | 111,072 | $0 |
| Aug 26, 2026 | SIMON IRWIN D President and CEO | Option exercise | 803,563 | $0 |
| Aug 6, 2026 | Gendel Mitchell Global General Counsel | Purchase | 2,500 | $11.1K |
| Aug 4, 2026 | Merton Carl A Chief Financial Officer | Purchase | 10,000 | $46.2K |
| Aug 3, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Purchase | 2,500 | $11.9K |
| Jul 30, 2026 | Gendel Mitchell Global General Counsel | Tax withheld | 12,921 | $54.3K |
| Jul 30, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | 26,120 | $0 |
| Jul 30, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Tax withheld | 13,844 | $58.1K |
| Jul 30, 2026 | Gendel Mitchell Global General Counsel | Option exercise | 24,379 | $0 |
| Jul 30, 2026 | Merton Carl A Chief Financial Officer | Option exercise | 16,656 | $0 |
| Jul 30, 2026 | Merton Carl A Chief Financial Officer | Tax withheld | 9,161 | $38.5K |
| Jul 30, 2026 | SIMON IRWIN D President and CEO | Option exercise | 117,647 | $0 |
| Jul 30, 2026 | SIMON IRWIN D President and CEO | Tax withheld | 62,353 | $261.9K |
| Jul 29, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Tax withheld | 49,654 | $198.1K |
| Jul 29, 2026 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | 93,685 | $0 |
| Jul 29, 2026 | SIMON IRWIN D President and CEO | Tax withheld | 227,078 | $906.0K |
| Jul 29, 2026 | SIMON IRWIN D President and CEO | Option exercise | 428,448 | $0 |
| Jul 29, 2026 | Merton Carl A Chief Financial Officer | Tax withheld | 30,209 | $120.5K |
| Jul 29, 2026 | Merton Carl A Chief Financial Officer | Option exercise | 60,417 | $0 |
| Jul 29, 2026 | Gendel Mitchell Global General Counsel | Tax withheld | 46,344 | $184.9K |
| Jul 29, 2026 | Gendel Mitchell Global General Counsel | Option exercise | 87,440 | $0 |
| Jul 29, 2026 | Clanachan David F Director | Tax withheld | 21,552 | $86.0K |
| Jul 29, 2026 | Clanachan David F Director | Option exercise | 43,104 | $0 |
| Jul 29, 2026 | Hopkinson David G. Director | Option exercise | 43,104 | $0 |
| Jul 29, 2026 | Persofsky Renah Director | Option exercise | 43,104 | $0 |
| Jul 29, 2026 | Looney Thomas P. Director | Option exercise | 43,104 | $0 |
| Jul 29, 2026 | Herhalt Johann Michael Director | Tax withheld | 21,552 | $86.0K |
| Jul 29, 2026 | Herhalt Johann Michael Director | Option exercise | 43,104 | $0 |
| Jul 29, 2026 | Cohen Steven Michael Director | Option exercise | 43,104 | $0 |
| Jul 29, 2026 | Persofsky Renah Director | Tax withheld | 21,552 | $86.0K |
| Apr 21, 2026 | Hopkinson David G. Director | Sale | 33,556 | $232.9K |
| Jan 7, 2026 | Cohen Steven Michael Director | Option exercise | 12,438 | $111.8K |
| Jul 31, 2025 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | 93,928 | $54.5K |
| Jul 31, 2025 | FALTISCHEK DENISE M Chief Strategy Officer | Tax withheld | 49,782 | $28.9K |
| Jul 31, 2025 | Gendel Mitchell Global General Counsel | Option exercise | 93,928 | $54.5K |
| Jul 31, 2025 | Gendel Mitchell Global General Counsel | Tax withheld | 49,782 | $28.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Tilray Brands, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading